Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1767-1777

  Rigamonti, Elena ^a   Touvier, Thierry ^b   Clementi, Emilio ^b,c   Manfredi, Angelo A ^a,d   Brunelli, Silvia ^a,e   Rovere Querini, Patrizia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD163 ANTIGEN; CD206 ANTIGEN; CD68 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MANNOSE RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MYOD PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CELL RECRUITMENT; CELLULAR PARAMETERS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VIVO STUDY; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MYOGENIC STEM CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; STEM CELL; UPREGULATION;

ACUTE DISEASE; ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; DISEASE MODELS, ANIMAL; INFLAMMATION; MACROPHAGES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DISEASES; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; REGENERATION; WOUND HEALING;

EID: 84873533655     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202903     Document Type: Article

References (47)

1. Chargé, S. B., and M. A. Rudnicki. 2004. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84: 209-238.
2. Paulsen, G., R. Crameri, H. B. Benestad, J. G. Fjeld, L. Mørkrid, J. Hallén, and T. Raastad. 2010. Time course of leukocyte accumulation in human muscle after eccentric exercise. Med. Sci. Sports Exerc. 42: 75-85.
3. Douglas, M. R., K. E. Morrison, M. Salmon, and C. D. Buckley. 2002. Why does inflammation persist: a dominant role for the stromal microenvironment? Expert Rev. Mol. Med. 4: 1-18.
4. Fielding, R. A., T. J. Manfredi, W. Ding, M. A. Fiatarone, W. J. Evans, and J. G. Cannon. 1993. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am. J. Physiol. 265: R166-R172.
5. Nguyen, H. X., A. J. Lusis, and J. G. Tidball. 2005. Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo. J. Physiol. 565: 403-413.
6. Chazaud, B., C. Sonnet, P. Lafuste, G. Bassez, A. C. Rimaniol, F. Poron, F. J. Authier, P. A. Dreyfus, and R. K. Gherardi. 2003. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 163: 1133-1143.
7. Tidball, J. G., and M. Wehling-Henricks. 2007. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J. Physiol. 578: 327-336.
8. Brunelli, S., and P. Rovere-Querini. 2008. The immune system and the repair of skeletal muscle. Pharmacol. Res. 58: 117-121.
9. Tidball, J. G., and S. A. Villalta. 2010. Regulatory interactions between muscle and the immune system during muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298: R1173-R1187.
10. De Palma, C., and E. Clementi. 2012. Nitric oxide in myogenesis and therapeutic muscle repair. Mol. Neurobiol. 46: 682-692.
11. Filippin, L. I., A. J. Moreira, N. P. Marroni, and R. M. Xavier. 2009. Nitric oxide and repair of skeletal muscle injury. Nitric Oxide 21: 157-163.
12. Stamler, J. S., and G. Meissner. 2001. Physiology of nitric oxide in skeletal muscle. Physiol. Rev. 81: 209-237.
13. Nisoli, E., E. Clementi, M. O. Carruba, and S. Moncada. 2007. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ. Res. 100: 795-806.
14. Buono, R., C. Vantaggiato, V. Pisa, E. Azzoni, M. T. Bassi, S. Brunelli, C. Sciorati, and E. Clementi. 2012. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP. Stem Cells 30: 197-209.
15. Silvagno, F., H. Xia, and D. S. Bredt. 1996. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. Biol. Chem. 271: 11204-11208.
16. Filippin, L. I., M. J. Cuevas, E. Lima, N. P. Marroni, J. Gonzalez-Gallego, and R. M. Xavier. 2011. Nitric oxide regulates the repair of injured skeletal muscle. Nitric Oxide 24: 43-49.
17. Filippin, L. I., M. J. Cuevas, E. Lima, N. P. Marroni, J. Gonzalez-Gallego, and R. M. Xavier. 2011. The role of nitric oxide during healing of trauma to the skeletal muscle. Inflamm. Res. 60: 347-356.
18. Vezzoli, M., P. Castellani, G. Corna, A. Castiglioni, L. Bosurgi, A. Monno, S. Brunelli, A. A. Manfredi, A. Rubartelli, and P. Rovere-Querini. 2011. Highmobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid. Redox Signal. 15: 2161-2174.
19. Pessina, P., V. Conti, R. Tonlorenzi, T. Touvier, R. Meneveri, G. Cossu, and S. Brunelli. 2012. Necdin enhances muscle reconstitution of dystrophic muscle by vessel-associated progenitors, by promoting cell survival and myogenic differentiation. Cell Death Differ. 19: 827-838.
20. Wiendl, H., R. Hohlfeld, and B. C. Kieseier. 2005. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 26: 373-380.
21. Robertson, T. A., M. A. Maley, M. D. Grounds, and J. M. Papadimitriou. 1993. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp. Cell Res. 207: 321-331.
22. McLennan, I. S. 1996. Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions. J. Anat. 188: 17-28.
23. Warren, G. L., T. Hulderman, D. Mishra, X. Gao, L. Millecchia, L. O'Farrell, W. A. Kuziel, and P. P. Simeonova. 2005. Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J. 19: 413-415.
24. Summan, M., G. L. Warren, R. R. Mercer, R. Chapman, T. Hulderman, N. Van Rooijen, and P. P. Simeonova. 2006. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R1488-R1495.
25. Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
26. Villalta, S. A., C. Rinaldi, B. Deng, G. Liu, B. Fedor, and J. G. Tidball. 2011. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum. Mol. Genet. 20: 790-805.
27. Segawa, M., S. Fukada, Y. Yamamoto, H. Yahagi, M. Kanematsu, M. Sato, T. Ito, A. Uezumi, S. Hayashi, Y. Miyagoe-Suzuki, et al. 2008. Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Exp. Cell Res. 314: 3232-3244.
28. Ruffell, D., F. Mourkioti, A. Gambardella, P. Kirstetter, R. G. Lopez, N. Rosenthal, and C. Nerlov. 2009. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl. Acad. Sci. USA 106: 17475-17480.
29. Anderson, J. E. 2000. A role for nitric oxide in muscle repair: nitric oxidemediated activation of muscle satellite cells. Mol. Biol. Cell 11: 1859-1874.
30. Tatsumi, R., X. Liu, A. Pulido, M. Morales, T. Sakata, S. Dial, A. Hattori, Y. Ikeuchi, and R. E. Allen. 2006. Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. Am. J. Physiol. Cell Physiol. 290: C1487-C1494.
31. Betters, J. L., J. H. Long, K. S. Howe, R. W. Braith, Q. A. Soltow, V. A. Lira, and D. S. Criswell. 2008. Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells. Muscle Nerve 37: 203-209.
32. Pisconti, A., S. Brunelli, M. Di Padova, C. De Palma, D. Deponti, S. Baesso, V. Sartorelli, G. Cossu, and E. Clementi. 2006. Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J. Cell Biol. 172: 233-244.
33. De Palma, C., S. Falcone, S. Pisoni, S. Cipolat, C. Panzeri, S. Pambianco, A. Pisconti, R. Allevi, M. T. Bassi, G. Cossu, et al. 2010. Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation. Cell Death Differ. 17: 1684-1696.
34. Colussi, C., C. Mozzetta, A. Gurtner, B. Illi, J. Rosati, S. Straino, G. Ragone, M. Pescatori, G. Zaccagnini, A. Antonini, et al. 2008. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc. Natl. Acad. Sci. USA 105: 19183-19187.
35. Cossu, G., and S. Biressi. 2005. Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin. Cell Dev. Biol. 16: 623-631.
36. Zammit, P. S., F. Relaix, Y. Nagata, A. P. Ruiz, C. A. Collins, T. A. Partridge, and J. R. Beauchamp. 2006. Pax7 and myogenic progression in skeletal muscle satellite cells. J. Cell Sci. 119: 1824-1832.
37. Church, J. E., S. M. Gehrig, A. Chee, T. Naim, J. Trieu, G. K. McConell, and G. S. Lynch. 2011. Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301: R1358-R1366.
38. Hickey, M. J., K. A. Sharkey, E. G. Sihota, P. H. Reinhardt, J. D. Macmicking, C. Nathan, and P. Kubes. 1997. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11: 955-964.
39. McCafferty, D. M., J. S. Mudgett, M. G. Swain, and P. Kubes. 1997. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112: 1022-1027.
40. Dumont, N., P. Bouchard, and J. Frenette. 2008. Neutrophil-induced skeletal muscle damage: a calculated and controlled response following hindlimb unloading and reloading. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295: R1831-R1838.
41. Zhang, L., L. Ran, G. E. Garcia, X. H. Wang, S. Han, J. Du, and W. E. Mitch. 2009. Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration. Am. J. Pathol. 175: 2518-2527.
42. Tidball, J. G. 1995. Inflammatory cell response to acute muscle injury. Med. Sci. Sports Exerc. 27: 1022-1032.
43. Lu, H., D. Huang, R. M. Ransohoff, and L. Zhou. 2011. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J. 25: 3344-3355.
44. Sciorati, C., R. Buono, E. Azzoni, S. Casati, P. Ciuffreda, G. D'Angelo, D. Cattaneo, S. Brunelli, and E. Clementi. 2010. Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans. Br. J. Pharmacol. 160: 1550-1560.
45. Sciorati, C., D. Miglietta, R. Buono, V. Pisa, D. Cattaneo, E. Azzoni, S. Brunelli, and E. Clementi. 2011. A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy. Pharmacol. Res. 64: 210-217.
46. Brunelli, S., C. Sciorati, G. D'Antona, A. Innocenzi, D. Covarello, B. G. Galvez, C. Perrotta, A. Monopoli, F. Sanvito, R. Bottinelli, et al. 2007. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc. Natl. Acad. Sci. USA 104: 264-269.
47. D'Angelo, M. G., S. Gandossini, F. Martinelli Boneschi, C. Sciorati, S. Bonato, E. Brighina, G. P. Comi, A. C. Turconi, F. Magri, G. Stefanoni, et al. 2012. Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. Pharmacol. Res. 65: 472-479.